IP Verse

Prolyl Hydroxylase Inhibitors And Methods Of Use - EP3357911

The patent EP3357911 was granted to Akebia Therapeutics on May 11, 2022. The application was originally filed on Jun 26, 2007 under application number EP18158907A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3357911

AKEBIA THERAPEUTICS
Application Number
EP18158907A
Filing Date
Jun 26, 2007
Status
Granted And Under Opposition
Apr 8, 2022
Grant Date
May 11, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

FIBROGENFeb 13, 2023CARPMAELS & RANSFORDWITHDRAWN

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
OPPOSITIONEP0650960
OPPOSITIONEP0650961
OPPOSITIONUS5607954
OPPOSITIONUS5610172
OPPOSITIONUS5620995
OPPOSITIONUS5620996
OPPOSITIONUS5668933
OPPOSITIONUS5719164
OPPOSITIONUS5726305
OPPOSITIONUS6020350
OPPOSITIONUS6093730
OPPOSITIONWO03049686
OPPOSITIONWO03053997
OPPOSITIONWO2004108121
SEARCHWO03049686
SEARCHWO03053997

Non-Patent Literature (NPL) Citations (15) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BUSSOLINO, F., Trends Biochem. Sci., (19970000), vol. 22, pages 251 - 256-
DESCRIPTION- FOLKMAN et al., Tumor Angiogenesis, pages 206 - 32-
DESCRIPTION- KRANTZ, S. B., "Erythropoietin", Blood, (19910000), vol. 77, pages 419 - 434-
DESCRIPTION- NGUYEN, L.L., Int. Rev. Cytol., (20010000), vol. 204, pages 1 - 48-
DESCRIPTION- O'REILLY et al., Cell, (19940000), vol. 79, pages 315 - 28-
DESCRIPTION- O'REILLY et al., Cell, (19970000), vol. 88, pages 277 - 85-
DESCRIPTION- SEMENZA, G. L. et al., "Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1", J. Biol. Chem., (19940000), vol. 269, pages 23757 - 63, XP000578184-
DESCRIPTION- SEMENZA, G.L., "Regulation of erythropoietin production: New insights into molecular mechanisms of oxygen homeostasis", Hematol. Oncol. Clin. North Am., (19940000), vol. 8, pages 863 - 884-
DESCRIPTION- TEISCHER et al., Int. J. Cancer, (19940000), vol. 57, pages 920 - 25-
DESCRIPTION- WEIDNER, New Eng. J. Med., (19910000), vol. 324, no. 1, pages 1 - 8-
OPPOSITION- Baringhaus K.-H, Guenzler-Pukall V, Schubert G, Weidmann K, Marion Roussel Hoechst, "3D QSAR OF PROLYL 4-HYDROXYLASE INHIBITORS", Molecular Modeling and Prediction of Bioactivity, Chapter 23, Springer, Boston, (20000101), pages 345 - 346, XP093028320-
OPPOSITION- Dekker Marcel, "Prolyl hydroxylase, protein disulfide isomerase, and other structurally related proteins", Prolyl 4-hydroxylase inhibitors, Chapter, (19980101), pages 96 - 95, XP093028314-
OPPOSITION- Ward Simon, "Exhibit SW2 to the first report of Simon Ward, filed on behalf of the Claimants in Claim No. HP-2018-000036 and the First and Second Defendants in IL-2019- 000031, and the Claimants in Claim No. HP-2018-000038 and the First and Second Defendants in Claim No. IL-2019-000032", The High Court of Justice Business and Property Courts of England and Wales Intellectual Property List, (ChD) Patents Cour, (20200103), pages 1 - 23, XP093028335-
OPPOSITION- Warshakoon, N.C. et al, "Design and synthesis of substituted pyridine derivatives as HIF-1@a prolyl hydroxylase inhibitors", Bioorganic & Medicinal Chemistry Letters, ELSEVIER, Amsterdam NL, Amsterdam NL , (20061101), vol. 16, no. 21, doi:10.1016/j.bmcl.2006.08.026, ISSN 0960-894X, pages 5616 - 5620, XP005663504
OPPOSITION- IVAN M,ET AL, "Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor.", Proceedings of the National Academy of Sciences, National Academy of Sciences, (20021015), vol. 99, no. 21, doi:10.1073/pnas.192342099, ISSN 0027-8424, pages 13459 - 13464, XP002232952

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents